IP Verse

Hikma Pharmaceuticals competitive analysis

Latest PTAB cases involving Hikma Pharmaceuticals

Discover the latest PTAB cases involving Hikma Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 3, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Hikma Pharmaceuticals

IPR2024-01418Sep 25, 2024HIKMA PHARMACEUTICALS USAAXSOME MALTATerminated-Settled
IPR2022-00215Nov 30, 2021HIKMA PHARMACEUTICALS USAAMARIN PHARMACEUTICALS IRELANDTerminated-Settled
IPR2018-00507Jan 17, 2018HIKMA PHARMACEUTICALSNOVARTIS PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Hikma Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HIKMA PHARMACEUTICALS USA - - 2 -
AMARIN PHARMACEUTICALS IRELAND - 15 - 1
AXSOME MALTA - 3 - 1